Bioventix PLC
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flo… Read more
Bioventix PLC (51B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: 0.160x
Based on the latest financial reports, Bioventix PLC (51B) has a cash flow conversion efficiency ratio of 0.160x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.90 Million) by net assets (€11.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioventix PLC - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Bioventix PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioventix PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioventix PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indomobil Sukses Internasional
JK:IMAS
|
-0.005x |
|
Rane (Madras) Limited
NSE:RML
|
0.035x |
|
TTEC Holdings Inc
NASDAQ:TTEC
|
0.019x |
|
289930
KQ:289930
|
-0.096x |
|
Premier Marketing Public Company Limited
BK:PM
|
0.134x |
|
Baazar Style Retail Limited
NSE:STYLEBAAZA
|
0.057x |
|
Robot Consulting Co., Ltd. ADS
NASDAQ:LAWR
|
N/A |
|
Berjaya Corporation Berhad
PINK:BRYAF
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Bioventix PLC (2017–2025)
The table below shows the annual cash flow conversion efficiency of Bioventix PLC from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | €11.55 Million | €7.03 Million | 0.609x | -12.44% |
| 2024-06-30 | €12.00 Million | €8.34 Million | 0.695x | +7.49% |
| 2023-06-30 | €12.06 Million | €7.80 Million | 0.647x | +1.17% |
| 2022-06-30 | €11.82 Million | €7.56 Million | 0.639x | +19.24% |
| 2021-06-30 | €11.82 Million | €6.34 Million | 0.536x | -12.63% |
| 2020-06-30 | €12.52 Million | €7.68 Million | 0.614x | +13.03% |
| 2019-06-30 | €10.83 Million | €5.88 Million | 0.543x | +0.94% |
| 2018-06-30 | €11.01 Million | €5.92 Million | 0.538x | +37.89% |
| 2017-06-30 | €10.14 Million | €3.96 Million | 0.390x | -- |